Connecticut SB00331 regulates step therapy requirements for prescription drugs under Medicaid, limiting duration and requiring coverage if deemed.

Connecticut SB00331 modifies Medicaid's step therapy requirements for prescription drugs. It mandates that step therapy durations must follow evidence-based guidelines from the drug manufacturer or FDA, or be no longer than 30 days. If a treatment is deemed ineffective after this period, the prescribed drug must be covered by Medicaid. This change affects Medicaid enrollees who require prescription drugs, ensuring they receive necessary treatments without excessive delays.

Connecticut SB00331 regulates step therapy requirements for prescription drugs under Medicaid, limiting duration and requiring coverage if deemed.

Connecticut SB00331 modifies Medicaid's step therapy requirements for prescription drugs. It mandates that step therapy durations must follow evidence-based guidelines from the drug manufacturer or FDA, or be no longer than 30 days. If a treatment is deemed ineffective after this period, the prescribed drug must be covered by Medicaid. This change affects Medicaid enrollees who require prescription drugs, ensuring they receive necessary treatments without excessive delays.